BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 30092766)

  • 1. Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers.
    Aiderus A; Black MA; Dunbier AK
    BMC Cancer; 2018 Aug; 18(1):805. PubMed ID: 30092766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of carnitine palmitoyl transferase 1A-induced fatty acid oxidation suppresses cell progression in gastric cancer.
    Wang L; Li C; Song Y; Yan Z
    Arch Biochem Biophys; 2020 Dec; 696():108664. PubMed ID: 33157102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
    Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
    Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of fatty acid oxidation by involvement of HIF-1α and PPARγ in human gastric adenocarcinoma and related clinical significance.
    Ezzeddini R; Taghikhani M; Salek Farrokhi A; Somi MH; Samadi N; Esfahani A; Rasaee MJ
    J Physiol Biochem; 2021 May; 77(2):249-260. PubMed ID: 33730333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
    Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y
    Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation.
    Du Q; Tan Z; Shi F; Tang M; Xie L; Zhao L; Li Y; Hu J; Zhou M; Bode A; Luo X; Cao Y
    Cancer Sci; 2019 Jun; 110(6):2050-2062. PubMed ID: 30945396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine palmitoyl transferase-1A (CPT1A): a new tumor specific target in human breast cancer.
    Pucci S; Zonetti MJ; Fisco T; Polidoro C; Bocchinfuso G; Palleschi A; Novelli G; Spagnoli LG; Mazzarelli P
    Oncotarget; 2016 Apr; 7(15):19982-96. PubMed ID: 26799588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing a relationship between prolactin and altered fatty acid β-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.
    Linher-Melville K; Zantinge S; Sanli T; Gerstein H; Tsakiridis T; Singh G
    BMC Cancer; 2011 Feb; 11():56. PubMed ID: 21294903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance.
    Wang T; Fahrmann JF; Lee H; Li YJ; Tripathi SC; Yue C; Zhang C; Lifshitz V; Song J; Yuan Y; Somlo G; Jandial R; Ann D; Hanash S; Jove R; Yu H
    Cell Metab; 2018 Jan; 27(1):136-150.e5. PubMed ID: 29249690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NQO1/CPT1A promotes the progression of pancreatic adenocarcinoma via fatty acid oxidation.
    Xu R; Liu Y; Ma L; Sun Y; Liu H; Yang Y; Jin T; Yang D
    Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):758-768. PubMed ID: 37249337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer.
    Camarda R; Zhou AY; Kohnz RA; Balakrishnan S; Mahieu C; Anderton B; Eyob H; Kajimura S; Tward A; Krings G; Nomura DK; Goga A
    Nat Med; 2016 Apr; 22(4):427-32. PubMed ID: 26950360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis.
    Wang YN; Zeng ZL; Lu J; Wang Y; Liu ZX; He MM; Zhao Q; Wang ZX; Li T; Lu YX; Wu QN; Yu K; Wang F; Pu HY; Li B; Jia WH; Shi M; Xie D; Kang TB; Huang P; Ju HQ; Xu RH
    Oncogene; 2018 Nov; 37(46):6025-6040. PubMed ID: 29995871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer.
    Jung YY; Kim HM; Koo JS
    PLoS One; 2015; 10(9):e0137204. PubMed ID: 26334757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma.
    Tang M; Dong X; Xiao L; Tan Z; Luo X; Yang L; Li W; Shi F; Li Y; Zhao L; Liu N; Du Q; Xie L; Hu J; Weng X; Fan J; Zhou J; Gao Q; Wu W; Zhang X; Liao W; Bode AM; Cao Y
    Cell Death Dis; 2022 Apr; 13(4):331. PubMed ID: 35411000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of CPT1A-mediated fatty acid oxidation in mesothelial cells protects against peritoneal fibrosis.
    Su W; Hu Z; Zhong X; Cong A; Zhang Y; Zhou Z; Li J; Su C; Huang Y; Cao W
    Theranostics; 2023; 13(13):4482-4496. PubMed ID: 37649600
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatty acid β-oxidation promotes breast cancer stemness and metastasis via the miRNA-328-3p-CPT1A pathway.
    Zeng F; Yao M; Wang Y; Zheng W; Liu S; Hou Z; Cheng X; Sun S; Li T; Zhao H; Luo Y; Li J
    Cancer Gene Ther; 2022 Mar; 29(3-4):383-395. PubMed ID: 34045663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing cancer-associated fibroblast fatty acid catabolism within a metabolically challenging tumor microenvironment drives colon cancer peritoneal metastasis.
    Peng S; Chen D; Cai J; Yuan Z; Huang B; Li Y; Wang H; Luo Q; Kuang Y; Liang W; Liu Z; Wang Q; Cui Y; Wang H; Liu X
    Mol Oncol; 2021 May; 15(5):1391-1411. PubMed ID: 33528867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting CPT1A enhances metabolic therapy in human melanoma cells with the BRAF V600E mutation.
    Sung GJ; Choi HK; Kwak S; Song JH; Ko H; Yoon HG; Kang HB; Choi KC
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):76-81. PubMed ID: 27793752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin promotes fatty acid oxidation and OXPHOS via the c-Myc/PGC-1 pathway in cancer cells.
    Liu Q; Sun Y; Fei Z; Yang Z; Duan K; Zi J; Cui Q; Yu M; Xiong W
    Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):707-714. PubMed ID: 31187140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer.
    Ahn S; Park JH; Grimm SL; Piyarathna DWB; Samanta T; Putluri V; Mezquita D; Fuqua SAW; Putluri N; Coarfa C; Kaipparettu BA
    Cancer Res; 2024 Jan; 84(2):291-304. PubMed ID: 37906431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.